pqq cofactor has been researched along with dinoprostone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hao, D; Kong, L; Ma, R; Yang, C; Yu, L; Zhang, J; Zhu, J; Zhu, Q | 1 |
1 other study(ies) available for pqq cofactor and dinoprostone
Article | Year |
---|---|
Pyrroloquinoline quinone (PQQ) inhibits lipopolysaccharide induced inflammation in part via downregulated NF-κB and p38/JNK activation in microglial and attenuates microglia activation in lipopolysaccharide treatment mice.
Topics: Animals; Anti-Inflammatory Agents; Brain; Calcium-Binding Proteins; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Drug Evaluation, Preclinical; Enzyme Activation; Female; Gene Expression; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; MAP Kinase Signaling System; Mice, Inbred C57BL; Microfilament Proteins; Microglia; p38 Mitogen-Activated Protein Kinases; PQQ Cofactor; Protein Processing, Post-Translational; Transcription Factor RelA | 2014 |